Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.
Identifieur interne : 002837 ( Ncbi/Merge ); précédent : 002836; suivant : 002838Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.
Auteurs : Davide Manca ; Giovanni Cossu ; Daniela Murgia ; Andrea Molari ; Paola Ferrigno ; Emanuele Marcia ; Maurizio MelisSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2009.
English descriptors
- KwdEn :
- Aged, Antiparkinson Agents (adverse effects), Antiparkinson Agents (therapeutic use), Catechols (adverse effects), Catechols (therapeutic use), Encephalitis (chemically induced), Female, Humans, Levodopa (adverse effects), Levodopa (therapeutic use), Nitriles (adverse effects), Nitriles (therapeutic use), Parkinson Disease (drug therapy), Peripheral Nervous System Diseases (chemically induced).
- MESH :
- chemical , adverse effects : Antiparkinson Agents, Catechols, Levodopa, Nitriles.
- chemical , therapeutic use : Antiparkinson Agents, Catechols, Levodopa, Nitriles.
- chemically induced : Encephalitis, Peripheral Nervous System Diseases.
- drug therapy : Parkinson Disease.
- Aged, Female, Humans.
DOI: 10.1002/mds.22807
PubMed: 19795477
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001B43
- to stream PubMed, to step Curation: 001B43
- to stream PubMed, to step Checkpoint: 001B79
Links to Exploration step
pubmed:19795477Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.</title>
<author><name sortKey="Manca, Davide" sort="Manca, Davide" uniqKey="Manca D" first="Davide" last="Manca">Davide Manca</name>
</author>
<author><name sortKey="Cossu, Giovanni" sort="Cossu, Giovanni" uniqKey="Cossu G" first="Giovanni" last="Cossu">Giovanni Cossu</name>
</author>
<author><name sortKey="Murgia, Daniela" sort="Murgia, Daniela" uniqKey="Murgia D" first="Daniela" last="Murgia">Daniela Murgia</name>
</author>
<author><name sortKey="Molari, Andrea" sort="Molari, Andrea" uniqKey="Molari A" first="Andrea" last="Molari">Andrea Molari</name>
</author>
<author><name sortKey="Ferrigno, Paola" sort="Ferrigno, Paola" uniqKey="Ferrigno P" first="Paola" last="Ferrigno">Paola Ferrigno</name>
</author>
<author><name sortKey="Marcia, Emanuele" sort="Marcia, Emanuele" uniqKey="Marcia E" first="Emanuele" last="Marcia">Emanuele Marcia</name>
</author>
<author><name sortKey="Melis, Maurizio" sort="Melis, Maurizio" uniqKey="Melis M" first="Maurizio" last="Melis">Maurizio Melis</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="doi">10.1002/mds.22807</idno>
<idno type="RBID">pubmed:19795477</idno>
<idno type="pmid">19795477</idno>
<idno type="wicri:Area/PubMed/Corpus">001B43</idno>
<idno type="wicri:Area/PubMed/Curation">001B43</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001B79</idno>
<idno type="wicri:Area/Ncbi/Merge">002837</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.</title>
<author><name sortKey="Manca, Davide" sort="Manca, Davide" uniqKey="Manca D" first="Davide" last="Manca">Davide Manca</name>
</author>
<author><name sortKey="Cossu, Giovanni" sort="Cossu, Giovanni" uniqKey="Cossu G" first="Giovanni" last="Cossu">Giovanni Cossu</name>
</author>
<author><name sortKey="Murgia, Daniela" sort="Murgia, Daniela" uniqKey="Murgia D" first="Daniela" last="Murgia">Daniela Murgia</name>
</author>
<author><name sortKey="Molari, Andrea" sort="Molari, Andrea" uniqKey="Molari A" first="Andrea" last="Molari">Andrea Molari</name>
</author>
<author><name sortKey="Ferrigno, Paola" sort="Ferrigno, Paola" uniqKey="Ferrigno P" first="Paola" last="Ferrigno">Paola Ferrigno</name>
</author>
<author><name sortKey="Marcia, Emanuele" sort="Marcia, Emanuele" uniqKey="Marcia E" first="Emanuele" last="Marcia">Emanuele Marcia</name>
</author>
<author><name sortKey="Melis, Maurizio" sort="Melis, Maurizio" uniqKey="Melis M" first="Maurizio" last="Melis">Maurizio Melis</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Catechols (adverse effects)</term>
<term>Catechols (therapeutic use)</term>
<term>Encephalitis (chemically induced)</term>
<term>Female</term>
<term>Humans</term>
<term>Levodopa (adverse effects)</term>
<term>Levodopa (therapeutic use)</term>
<term>Nitriles (adverse effects)</term>
<term>Nitriles (therapeutic use)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Peripheral Nervous System Diseases (chemically induced)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Catechols</term>
<term>Levodopa</term>
<term>Nitriles</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Catechols</term>
<term>Levodopa</term>
<term>Nitriles</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Encephalitis</term>
<term>Peripheral Nervous System Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Female</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">19795477</PMID>
<DateCreated><Year>2009</Year>
<Month>11</Month>
<Day>30</Day>
</DateCreated>
<DateCompleted><Year>2010</Year>
<Month>02</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>24</Volume>
<Issue>15</Issue>
<PubDate><Year>2009</Year>
<Month>Nov</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.</ArticleTitle>
<Pagination><MedlinePgn>2293-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.22807</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Manca</LastName>
<ForeName>Davide</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Cossu</LastName>
<ForeName>Giovanni</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Murgia</LastName>
<ForeName>Daniela</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Molari</LastName>
<ForeName>Andrea</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ferrigno</LastName>
<ForeName>Paola</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Marcia</LastName>
<ForeName>Emanuele</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Melis</LastName>
<ForeName>Maurizio</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002396">Catechols</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009570">Nitriles</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>46627O600J</RegistryNumber>
<NameOfSubstance UI="D007980">Levodopa</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4975G9NM6T</RegistryNumber>
<NameOfSubstance UI="C071192">entacapone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D002396">Catechols</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004660">Encephalitis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007980">Levodopa</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009570">Nitriles</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010523">Peripheral Nervous System Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>10</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>10</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>2</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.22807</ArticleId>
<ArticleId IdType="pubmed">19795477</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Cossu, Giovanni" sort="Cossu, Giovanni" uniqKey="Cossu G" first="Giovanni" last="Cossu">Giovanni Cossu</name>
<name sortKey="Ferrigno, Paola" sort="Ferrigno, Paola" uniqKey="Ferrigno P" first="Paola" last="Ferrigno">Paola Ferrigno</name>
<name sortKey="Manca, Davide" sort="Manca, Davide" uniqKey="Manca D" first="Davide" last="Manca">Davide Manca</name>
<name sortKey="Marcia, Emanuele" sort="Marcia, Emanuele" uniqKey="Marcia E" first="Emanuele" last="Marcia">Emanuele Marcia</name>
<name sortKey="Melis, Maurizio" sort="Melis, Maurizio" uniqKey="Melis M" first="Maurizio" last="Melis">Maurizio Melis</name>
<name sortKey="Molari, Andrea" sort="Molari, Andrea" uniqKey="Molari A" first="Andrea" last="Molari">Andrea Molari</name>
<name sortKey="Murgia, Daniela" sort="Murgia, Daniela" uniqKey="Murgia D" first="Daniela" last="Murgia">Daniela Murgia</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002837 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002837 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:19795477 |texte= Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:19795477" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |